-
- Elsa Bernard
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York
-
- Peter L. Greenberg
- Stanford University Cancer Institute, Stanford, CA
-
- Robert P. Hasserjian
- Department of Pathology, Massachusetts General Hospital, Boston
-
- Juan E. Arango Ossa
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York
-
- Yasuhito Nannya
- Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan
-
- Sean M. Devlin
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York
-
- Maria Creignou
- Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm
-
- Philippe Pinel
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York
-
- Lily Monnier
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York
-
- Gunes Gundem
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York
-
- Juan S. Medina-Martinez
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York
-
- Dylan Domenico
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York
-
- Martin Jädersten
- Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm
-
- Ulrich Germing
- Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany
-
- Guillermo Sanz
- Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
-
- Arjan A. van de Loosdrecht
- Department of Hematology, Amsterdam University Medical Center, Vrije University Medical Center, Amsterdam
-
- Olivier Kosmider
- Department of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin and Université de Paris, Université Paris Descartes, Paris
-
- Matilde Y. Follo
- Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy
-
- Felicitas Thol
- Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
-
- Lurdes Zamora
- Hematology Department, Hospital Germans Trias i Pujol, Institut Català d’Oncologia, Josep Carreras Leukaemia Research Institute, Barcelona
-
- Ronald F. Pinheiro
- Drug Research and Development Center, Federal University of Ceara, Ceara, Brazil
-
- Andrea Pellagatti
- Radcliffe Department of Medicine, Oxford BRC Haematology Theme, University of Oxford, Oxford, United Kingdom
-
- Harold K. Elias
- Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
-
- Detlef Haase
- Clinics of Hematology and Medical Oncology, University Medical Center, Göttingen, Germany
-
- Christina Ganster
- Clinics of Hematology and Medical Oncology, University Medical Center, Göttingen, Germany
-
- Lionel Ades
- Department of Hematology, Hôpital St Louis, and Paris University, Paris
-
- Magnus Tobiasson
- Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm
-
- Laura Palomo
- Myelodysplastic Syndromes Group<!--<Changed "Syndromes" to have a capital "S", deleted the second instance of "Group" (RL)>-->, Institut de Recerca Contra la Leucèmia Josep Carreras, Barcelona
-
- Matteo Giovanni Della Porta
- Cancer Center, Humanitas Research Hospital & Humanitas University, Milan
-
- Akifumi Takaori-Kondo
- Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
-
- Takayuki Ishikawa
- Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan
-
- Shigeru Chiba
- Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
-
- Senji Kasahara
- Department of Hematology, Gifu Municipal Hospital, Gifu, Japan
-
- Yasushi Miyazaki
- Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan
-
- Agnes Viale
- Integrated Genomics Operation, Memorial Sloan Kettering Cancer Center, New York
-
- Kety Huberman
- Integrated Genomics Operation, Memorial Sloan Kettering Cancer Center, New York
-
- Pierre Fenaux
- Department of Hematology, Hôpital St Louis, and Paris University, Paris
-
- Monika Belickova
- Department of Genomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
-
- Michael R. Savona
- Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville
-
- Virginia M. Klimek
- Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
-
- Fabio P. S. Santos
- Oncology-Hematology Center, Hospital Israelita Albert Einstein, São Paulo
-
- Jacqueline Boultwood
- Radcliffe Department of Medicine, Oxford BRC Haematology Theme, University of Oxford, Oxford, United Kingdom
-
- Ioannis Kotsianidis
- Department of Hematology, Democritus University of Thrace Medical School, Alexandroupolis, Greece
-
- Valeria Santini
- Myelodysplastic syndromes Unit, Department of Experimental and Clinical Medicine, Hematology, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy
-
- Francesc Solé
- Myelodysplastic Syndromes Group<!--<Changed "Syndromes" to have a capital "S", deleted the second instance of "Group" (RL)>-->, Institut de Recerca Contra la Leucèmia Josep Carreras, Barcelona
-
- Uwe Platzbecker
- Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University of Leipzig, Leipzig, Germany
-
- Michael Heuser
- Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
-
- Peter Valent
- Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna
-
- Kazuma Ohyashiki
- Tokyo Medical University, Tokyo
-
- Carlo Finelli
- Institute of Hematology “Seràgnoli,” Istituti di Ricovero e Cura a Carattere Scientifico Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
-
- Maria Teresa Voso
- Myelodysplastic syndromes Cooperative Group Gruppo Laziale Mielodisplasie (GROM-L), Department of Biomedicine and Prevention, Tor Vergata University, Rome
-
- Lee-Yung Shih
- Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taiwan
-
- Michaela Fontenay
- Department of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin and Université de Paris, Université Paris Descartes, Paris
-
- Joop H. Jansen
- Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands
-
- José Cervera
- Department of Hematology and Genetics Unit, University Hospital La Fe, Valencia, Spain
-
- Norbert Gattermann
- Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany
-
- Benjamin L. Ebert
- Department of Medical Oncology, Howard Hughes Medical Institute, Dana-Farber Cancer Center, Boston
-
- Rafael Bejar
- University of California San Diego Moores Cancer Center, La Jolla, CA
-
- Luca Malcovati
- Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo and University of Pavia, Pavia, Italy
-
- Mario Cazzola
- Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo and University of Pavia, Pavia, Italy
-
- Seishi Ogawa
- Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan
-
- Eva Hellström-Lindberg
- Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm
-
- Elli Papaemmanuil
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York
収録刊行物
-
- NEJM Evidence
-
NEJM Evidence 1 (7), EVIDoa2200008-, 2022-06-28
Massachusetts Medical Society